The U.S. Food and Drug Administration (FDA) is interested in the development of resources to reduce the use of opioids where alternatives exist, so ACEP shared its extensive opioid resources. To view those resources, click here. Our two opioid-related point-of-care tools—MAP (managing acute pain) and BUPE (buprenorphine)—are now available on our new app, emPOC, available through the Apple Store and Google Play.
ACEP Shares Opioid Resources with FDA
Topics: emPOC appFDAOpioid CrisisOpioidsPoint-of-CareTechnology
Related
-
Tread Cautiously with Artificial Intelligence in Clinical Scenarios
July 8, 2024 - 0 Comment -
How to Manage Elderly Patient Pain without Opioids
February 13, 2024 - 0 Comment -
Augmenting Medical Education with Virutal Reality
February 6, 2024 - 0 Comment
No Responses to “ACEP Shares Opioid Resources with FDA”